The booming popularity of weight-loss drugs in the United States is creating an unexpected windfall for candy giant Hershey. The company has reported a surge in demand for its mints and chewing gums, driven by users of GLP-1 medications who are grappling with a side effect known as 'Ozempic breath.'
What Is Ozempic Breath?
This condition, linked to slower digestion, dry mouth, and sulfur-like burps, has prompted many individuals to seek out products like Hershey's Ice Breakers gum to maintain fresh breath. According to Hershey CEO Kirk Tanner, the company has observed strong demand for gum and mint products, which he attributes to 'functional snacking tailwinds' stemming from the rapid adoption of these drugs.
Sales Figures and Market Impact
Ice Breakers, now Hershey's third-largest confectionery line, experienced an 8% increase in retail sales during the first quarter of this year. Tanner noted that the gum and mint category is directly benefiting from the new wave of weight-loss drug users. This trend highlights a curious twist in the GLP-1 revolution, which had previously been blamed for reducing demand in certain food sectors as users consume less.
However, rather than abandoning treats entirely, many consumers are changing how they indulge. Hershey's chocolate sales remain robust, with Tanner describing chocolate as 'an emotional category' that people still enjoy in small portions. 'It is a treat, not a meal,' he said.
Shift Toward Protein Bars
The company also reported a 17% surge in protein bar consumption, as users of weight-loss drugs shift toward higher-protein diets to preserve muscle mass while losing weight. This aligns with broader dietary changes observed among GLP-1 users.
Public Reaction
The revelation that Ozempic breath is boosting gum sales has sparked a mix of humor and skepticism online. One user on X commented, 'Ozempic killed your appetite for food but created a whole new market for mints. Big Pharma accidentally saved Big Gum.' Another added, 'Invent a drug, create a side effect, sell the solution. Vertical integration at its finest.' Some were more blunt, joking about 'dragon breath' and warning that bad breath may be the least of users' concerns regarding the drugs' side effects.
GLP-1 drugs, originally developed to treat diabetes, have exploded in popularity as weight-loss tools, reshaping everything from grocery shopping habits to restaurant demand. Now, they are quietly transforming another corner of the consumer economy: the humble mint tin and gum packet. Hershey, known for chocolates like Reese's and Kit Kats, also owns snacks such as SkinnyPop and Dot's Homestyle Pretzels, and recently debuted the new Reese's Marshmallow Cup.
